Screener
Akebia Therapeutics AKBA Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue$62.5MBeat by $14.6M
EPS$0.00Beat by $0.02
Revenue estimate$47.9M
EPS estimate-$0.02
Next report
Nov 9, 2026 (in 2 months)Revenue estimate$46.9M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Akebia Therapeutics report Q2 2025 earnings?
- Akebia Therapeutics (AKBA) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Akebia Therapeutics's Q2 2025 revenue and EPS?
- Akebia Therapeutics reported revenue of $62.5M and eps of $0.00 for Q2 2025.
- Did Akebia Therapeutics beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $47.9M by $14.6M. EPS beat the consensus estimate of $-0.02 by $0.02.
- How did Akebia Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 43.1% from $43.6M a year earlier.
- Where can I find Akebia Therapeutics's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001517022-25-000034) and the 10-Q periodic report (0001628280-25-038600) directly on SEC EDGAR. The filing index links above go to sec.gov.
